US Stock MarketDetailed Quotes

CERT Certara

Watchlist
  • 11.270
  • +0.340+3.11%
Close Nov 27 16:00 ET
  • 11.270
  • 0.0000.00%
Post 20:01 ET
1.81BMarket Cap-56350P/E (TTM)

About Certara Company

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Company Profile

SymbolCERT
Company NameCertara
Listing DateDec 11, 2020
Issue Price23.00
Founded2017
CEODr. William F. Feehery, PhD
MarketNASDAQ
Employees1391
Fiscal Year Ends12-31
Address4 Radnor Corporate Center,Suite 350
CityRadnor
ProvincePennsylvania
CountryUnited States of America
Zip Code19087
Phone1-415-237-8772
Websitehttp://www.certara.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William F. Feehery, PhD
  • Director and Chief Executive Officer
  • 7.81M
  • Nicolette D. Sherman
  • Chief Human Resources Officer
  • --
  • John E. Gallagher
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 4.24M
  • Leif E. Pedersen
  • President and Chief Commercial Officer
  • 2.14M
  • Richard M. Traynor
  • Senior Vice President and General Counsel
  • --
  • James E. Cashman, III
  • Chairman of the Board
  • 319.51K
  • Dr. Robert Aspbury, PhD
  • President, Certara Scientific Software
  • 2.09M
  • Patrick F Smith
  • President, Integrated Drug Development
  • 2.42M
  • Dr. John V. W. Reynders
  • Director
  • --
  • Nancy Killefer
  • Independent Director
  • 252.01K
  • Stephen M. McLean
  • Independent Director
  • --
  • David Spaight
  • Independent Director
  • --
  • Rosemary A. Crane, M.B.A.
  • Independent Director
  • 239.51K
  • Eran Broshy
  • Independent Director
  • 252.01K
  • Matthew M. Walsh
  • Independent Director
  • 252.01K
  • Cynthia Lynne Collins
  • Independent Director
  • 242.01K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data